• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA Rejects Aldeyra’s Dry Eye Drug, Cites Need for Additional Trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 29, 2023 at 12:42: PM
via The FDA on Monday rejected Aldeyra Therapeutics’ investigational reactive aldehyde species modulator reproxalap, which the company is proposing as a treatment for dry eye disease.

article source
 

<



Similar threads

cafead
Aldeyra Therapeutics reports that FDA rejects eye cancer drug
Replies
0
Views
180
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Rejects Rocket’s Gene Therapy, Cites Need for Additional CMC Info
Replies
0
Views
49
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
Replies
0
Views
175
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues
Replies
0
Views
113
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Adcomm Rejects BrainStorm’s ALS Therapy in Nearly Unanimous Vote
Replies
0
Views
135
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote